Veröffentlichungen | MDC Berlin

7 Ergebnisse:

Active Filter:

01. Juni 2016 in Clin Cancer Res

Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation

M. Leisegang
B. Engels
K. Schreiber
P.Y. Yew
K. Kiyotani
C. Idel
A. Arina
J. Duraiswamy
R.R. Weichselbaum
W. Uckert
Y. Nakamura
H. Schreiber

01. März 2016 in J Clin Invest

Targeting human melanoma neoantigens by T cell receptor gene therapy

M. Leisegang
T. Kammertoens
W. Uckert
T. Blankenstein

01. November 2010 in J Clin Invest

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors

M. Leisegang
S. Wilde
S. Spranger
S. Milosevic
B. Frankenberger
W. Uckert
D.J. Schendel

01. November 2010 in J Mol Med

Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes

P. Meyerhuber
H. Conrad
L. Staerck
M. Leisegang
D.H. Busch
W. Uckert
H. Bernhard

15. April 2010 in Clin Cancer Res

T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy

M. Leisegang
A. Turqueti-Neves
B. Engels
T. Blankenstein
D.J. Schendel
W. Uckert
E. Noessner

01. Februar 2010 in J Immunol

A single TCRα-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire

X. Liang
L.U. Weigand
I.G. Schuster
E. Eppinger
J.C. van der Griendt
A. Schub
M. Leisegang
D. Sommermeyer
F. Anderl
Y. Han
J. Ellwart
A. Moosmann
D.H. Busch
W. Uckert
C. Peschel
A.M. Krackhardt

01. November 2006 in Eur J Immunol

Designer T cells by T cell receptor replacement

D. Sommermeyer
J. Neudorfer
M. Weinhold
M. Leisegang
B. Engels
E. Noessner
M.H. Heemskerk
J. Charo
D.J. Schendel
T. Blankenstein
H. Bernhard
W. Uckert